How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Tax Reform Technical Corrections, Medical Device Tax Repeal (S.692)
Medical Device tax Repeal (S. 692), FDARA Implementation
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2019 · first_quarter · Q1
Tax Reform Technical Corrections, Medical Device Tax Repeal (S.692)
Medical Device tax Repeal (S. 692), FDARA Implementation
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Source: Senate LDA
To amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications.
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
To amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications.
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments for granting export certifications.
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments for granting export certifications.
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
Protect Medical Innovation Act of 2013
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Medical Device Tax Repeal (HR 523 and S 232)
Medical Device Access and Innovation Protection Act
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Medical Device Tax Repeal (HR 523 and S 232)
Health Care Cost Reduction Act of 2012
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
medical device tax repeal, S 17, S 262, HR 436, HR 488, HR 736 and corporate tax reform
Health Care Cost Reduction Act of 2012
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Med Device Tax Repeal H.R. 436 S.17
Health Care Cost Reduction Act of 2012
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Medical device tax repeal - HR 436
medical device tax repeal, S 17, S 262, HR 436, HR 488, HR 736 and corporate tax reform
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
FDA Appropriations H.R. 5973
Build America Bonds Extension for Rural and Urban Transportation and Highways Act of 2011
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
medical device tax repeal, S 17, S 262, HR 436, HR 488, HR 736 and corporate tax reform
Premarket Predictability Act of 2011
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
S. 17, H.R. 436 - Medical Device Tax Repeal H.R. 3209, 3203, 3230, 3205, 3211, 3208, 3206, 3214, 3207, 3204 and S. 1700, 1865, 1943, 1972, 1995 - FDA Policy Physician-owned Distributors
Health Care Cost Reduction Act of 2012
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
PL 111-148 implementation and medical device tax repeal (s17, s262, HR 436, HR 488, HR 736)
Health Care Cost Reduction Act of 2012
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
S. 17, H.R. 436 - Medical Device Tax Repeal H.R. 3209, 3203, 3230, 3205, 3211, 3208, 3206, 3214, 3207, 3204 and S. 1700, 1865, 1943, 1972, 1995 - FDA Policy Physician-owned Distributors
Health Care Cost Reduction Act of 2012
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Medical device tax repeal, S 17, S 262, HR 436, HR 488, HR 736 Corporate tax reform
Health Care Cost Reduction Act of 2012
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
PL 111-148 Implementation and Medical Device Tax Repeal (S 17, S 262, HR 436, HR 488, HR 736)
PL 111-148 implementation and medical device tax repeal (s17, s262, HR 436, HR 488, HR 736)
PL 111-148 Implementation and Medical Device Tax Repeal (S 17, S 262, HR 436, HR 488, HR 736)
Medical device tax repeal, S 17, S 262, HR 436, HR 488, HR 736 Corporate tax reform
Build America Bonds Extension for Rural and Urban Transportation and Highways Act of 2011
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
PL 111-148 Implementation and Medical Device Tax Repeal (S 17, S 262, HR 436, HR 488, HR 736)
Build America Bonds Extension for Rural and Urban Transportation and Highways Act of 2011
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
PL 111-148 implementation and medical device tax repeal (s17, s262, HR 436, HR 488, HR 736)
Build America Bonds Extension for Rural and Urban Transportation and Highways Act of 2011
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Medical device tax repeal, S 17, S 262, HR 436, HR 488, HR 736 Corporate tax reform
To amend title 35, United States Code, to provide recourse under the patent law for persons who suffer competitive injury as a result of false markings.
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Patent reform legislation S 515, Patent false marking (HR 4954)
Creating American Jobs and Ending Offshoring Act
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Tax extenders (R&D credit, CFC look thru and international provisions - HR 4213 American Workers, State, and Business Relief Act of 2010, S 3816 Creating American Jobs and Ending Offshoring Act, and international tax provisions)
Patent Reform - S.515 Manager's Amendment
Patent reform legislation S 515, Patent false marking (HR 4954)
American Middle Class Tax (AMT) Relief Act of 2007
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Health Care Reform bills, specifically HR 3590 and Health Care and Education Affordability Reconciliation Act
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Tax deferral, R&D credit, House and Senate Budget Resolutions (H. Con. Res 85 and S. Con Res. 13)
National Knee and Hip Replacement Registry Act of 2009
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
National Joint Registry (HR 2813), FDA 510(k) issues, H Res 577 (Orthopedic Resolution) Various health care reform draft bills from the House Tri-Committees and Senate HELP and Finance Committees
Derivative Trading Accountability and Disclosure Act
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Over the Counter Derivatives legislation especially HR 3300 and HR 977 and S 272 and S 1691
Derivatives Markets Transparency and Accountability Act of 2009
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Over the Counter Derivatives legislation especially HR 3300 and HR 977 and S 272 and S 1691
Recognizing the Nation's orthopedic industry for its continued legacy of innovation in providing devices that relieve the pain of, and restore mobility to, active duty armed service members, veterans, and patients of all ages from all walks of life.
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
National Joint Registry (HR 2813), FDA 510(k) issues, H Res 577 (Orthopedic Resolution) Various health care reform draft bills from the House Tri-Committees and Senate HELP and Finance Committees
Comprehensive Derivatives Regulation Act of 2009
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Over the Counter Derivatives legislation especially HR 3300 and HR 977 and S 272 and S 1691
Derivatives Trading Integrity Act of 2009
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Over the Counter Derivatives legislation especially HR 3300 and HR 977 and S 272 and S 1691
To amend the Internal Revenue Code of 1986 to prevent corporations from exploiting tax treaties to evade taxation of United States income.
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
FDA Sentinel Initiative (post market surveillance); H.R. 3580; FDA Guidance Documents; H.R. 3160 - Import Safety; Federal Preemption (S.3398 and H.R. 6381); Direct to Consumer Ads (H.R. 6151)
Food and Drug Administration Amendments Act of 2007
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
FDA Sentinel Initiative (post market surveillance); H.R. 3580; FDA Guidance Documents; H.R. 3160 - Import Safety; Federal Preemption (S.3398 and H.R. 6381); Direct to Consumer Ads (H.R. 6151)
Physician Payments Sunshine Act of 2008
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
S. 2029 and H.R. 5605 Physician Payment Sunshine Act Medicare CY09 Physician Fee Schedule Proposed Rule S.3408 Comparative Effectiveness Research Act of 2008
Responsibility in Drug and Device Advertising Act of 2008
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
FDA Sentinel Initiative (post market surveillance); H.R. 3580; FDA Guidance Documents; H.R. 3160 - Import Safety; Federal Preemption (S.3398 and H.R. 6381); Direct to Consumer Ads (H.R. 6151)
FDA Sentinel Initiative (post market surveillance); H.R. 3580; FDA Guidance Documents; H.R. 3160 - Import Safety; Federal Preemption (S.3398 and H.R. 6381); Direct to Consumer Ads (H.R. 6151)
Physician Payments Sunshine Act of 2007
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
S. 2029 and H.R. 5605 Physician Payment Sunshine Act Medicare CY09 Physician Fee Schedule Proposed Rule S.3408 Comparative Effectiveness Research Act of 2008
R&D Tax Credit/CFC Look Thru (tax extenders legislation, H.R. 1424, S.334)
FDA Sentinel Initiative (post market surveillance); H.R. 3580; FDA Guidance Documents; H.R. 3160 - Import Safety; Federal Preemption (S.3398 and H.R. 6381); Direct to Consumer Ads (H.R. 6151)
Comparative Effectiveness Research Act of 2008
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
S. 2029 and H.R. 5605 Physician Payment Sunshine Act Medicare CY09 Physician Fee Schedule Proposed Rule S.3408 Comparative Effectiveness Research Act of 2008
American Samoa Possession Tax Credit Act of 2003
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
R&D Tax Credit/CFC Look Thru (tax extenders legislation, H.R. 1424, S.334)
2018 · fourth_quarter · Q4
VA Procurement
MDET repeal, technical corrections to TCJA
MDET repeal, FDARA implementation
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2018 · third_quarter · Q3
MDET repeal, tax reform
VA Procurement
MDET repeal, VA Procurement, FDARA implementation, Sunshine Open Payments
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2018 · second_quarter · Q2
MDET repeal, tax reform
MDET repeal, VA Procurement, FDARA implementation, Sunshine Open Payments
VA Procurement
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2018 · first_quarter · Q1
VA Procurement
MDET repeal in January CR spending bill
MDET repeal, tax reform
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2017 · fourth_quarter · Q4
MDET repeal, tax reform
MDET repeal
VA Procurement
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2017 · third_quarter · Q3
MDET repeal, tax reform
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2017 · second_quarter · Q2
MDET repeal, tax reform
MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2017 · first_quarter · Q1
MDUFA Reauthorization, FDA Inspections, MDET repeal
MDET repeal, tax reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2016 · fourth_quarter · Q4
FDA User Fee Reauthorization; FDA re-processing regulations, FDA facility inspection process reforms
MDET Repeal; Corporate Tax Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2016 · second_quarter · 2A
Corporate Tax Reform, MDET Repeal
Energy and Commerce Committee's 21st Century Cures; Medicare payment (CCJR and proposed Medicare Inpatient Payment and Physician Payment Rules); FDA inspections; FY17 Ag Appropriations; MDUFA Reauthorization; FDA re-processing regulations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2016 · second_quarter · Q2
Energy and Commerce Committee's 21st Century Cures; Medicare payment (CCJR and proposed Medicare Inpatient Payment and Physician Payment Rules); FDA inspections; FY17 Ag Appropriations; MDUFA Reauthorization; FDA re-processing regulations
Corporate Tax Reform, MDET Repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2016 · first_quarter · Q1
Corporate Tax Reform
Energy and Commerce Committee's 21st Century Cures; Medicare payment (CCJR); FDA inspections; FY17 Ag Appropriations; MDUFA Reauthorization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2015 · fourth_quarter · Q4
Energy and Commerce Committee's 21st Century Cures; VA Healthcare Vendor Credentialing; Medicare payment (CCJR); Device Distributor Licensing
Corporate Tax Reform; Medical Device Excise Tax Repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2015 · third_quarter · Q3
Energy and Commerce Committee's 21st Century Cures; VA Healthcare Vendor Credentialing; FDA reform; Medicare payment (CCJR)
Corporate Tax Reform; Medical Device Excise Tax Repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2015 · second_quarter · Q2
Corporate Tax Reform; Medical Device Excise Tax Repeal
Energy and Commerce Committee's 21st Century Cures
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2015 · first_quarter · Q1
FDA Sequestration; Energy and Commerce Committee's 21st Century Cures; Medicare Payment Reforms (Bundled Payment/Gainsharing)
Corporate Tax Reform; Medical Device Excise Tax Repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2014 · fourth_quarter · Q4
HEALTH - 21st Century Cures Initiative, FDA House bills in draft
TAX - Medical Device Excise Tax Repeal Bills House and Senate; Corporate Tax Extenders
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2014 · third_quarter · Q3
Tax Reform and Tax Extenders
Medical Device Excise Tax; Implementation of the Food and Drug Administration Safety and Innovation Act; Energy & Commerce Committee's 21st Century Cures Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2014 · second_quarter · Q2
FDASIA Implementation
Tax reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2014 · first_quarter · Q1
Tax reform and Tax Extenders
FDASIA Implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2013 · fourth_quarter · Q4
Medical Device Tax Repeal (HR 523 and S 232)
Corporate tax reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2013 · third_quarter · Q3
Corporate tax reform
Medicare payment (ACO/bundled payments/Physician Payment Proposed rule)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2013 · second_quarter · Q2
Corporate tax reform
FDA UDI Rule; FDA user fee/sequestration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2013 · first_quarter · Q1
Corporate Tax Reform
Medical Device Repeal; Implementation of the Food and Drug Administration Safety and Innovation Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2012 · fourth_quarter · Q4
Medical Device Tax Repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2012 · third_quarter · Q3
Med Device Tax Repeal H.R. 436 S.17
Corporate Tax Reform
FDA Appropriations H.R. 5973
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2012 · second_quarter · Q2
Medical device user fee reauthorization legislation - FDA Safety and Innovation Act, including custom device provision of the act
Medical device tax repeal - HR 436
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2012 · first_quarter · Q1
FDA medical device user fee reauthorization, custom device issues and reprocessing of single use devices, and musculoskeletal health disparities congressional resolution
medical device tax repeal, S 17, S 262, HR 436, HR 488, HR 736 and corporate tax reform
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2011 · fourth_quarter · Q4
S. 17, H.R. 436 - Medical Device Tax Repeal H.R. 3209, 3203, 3230, 3205, 3211, 3208, 3206, 3214, 3207, 3204 and S. 1700, 1865, 1943, 1972, 1995 - FDA Policy Physician-owned Distributors
Conflict Minerals Regulations
Corporate Tax Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2011 · third_quarter · Q3
FDA 510k reform and Medical Device User Fees and PPACA (health care law) implementation and Musculoskeletal Health Disparties Summit in D.C.
Medical device tax repeal, S 17, S 262, HR 436, HR 488, HR 736 Corporate tax reform
Patent reform, HR 1249 and S 23
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2011 · second_quarter · Q2
PL 111-148 implementation and medical device tax repeal (s17, s262, HR 436, HR 488, HR 736)
HR 1249 and S 23 regarding patent reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2011 · first_quarter · Q1
Patent Reform, HR 1249 and S 23
Corporate Tax Reform
PL 111-148 Implementation and Medical Device Tax Repeal (S 17, S 262, HR 436, HR 488, HR 736)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2010 · fourth_quarter · Q4
FDA Reform, PPACA implementation (CER, Sunshine), Gainsharing
Corporate International Tax Provisions Tax Reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2010 · third_quarter · Q3
FDA 510(k) Reform, Implementation of Sunshine provision of PPACA health care reform law, Implementation of Comparative Effectiveness Research provision of PPACA health care reform law, GAO study on implantable medical device pricing matters, Sen Grassley inquiry of Zimmer based on NY Time article re orthopedic surgeons
Patent reform legislation S 515, Patent false marking (HR 4954)
Tax extenders (R&D credit, CFC look thru and international provisions - HR 4213 American Workers, State, and Business Relief Act of 2010, S 3816 Creating American Jobs and Ending Offshoring Act, and international tax provisions)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2010 · second_quarter · Q2
Tax Extenders (R&D Credit, CFC Look thru, and international provisions - H.R. 4213 American Workers, State, and Business Relief Act of 2010)
Patent Reform - S.515 Manager's Amendment
OTC Derivatives (H.R. 4173 Wall Street Reform and Consumer Protection Act of 2009)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2010 · first_quarter · Q1
OTC Derivatives, with emphasis on HR 4173 Wall Street Reform and Consumer Protection Act of 2009
Health Care Reform bills, specifically HR 3590 and Health Care and Education Affordability Reconciliation Act
Tax extenders, with emphasis on R&D tax credit and CFC look thru, HR 4213 American Workers, State and Business Relief Act of 2010
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2009 · fourth_quarter · Q4
Over the Counter Derivatives legislation especially HR 3300 and HR 977 and S 272 and S 1691
International tax reform related issues like deferral plus corporate tax related issues like tax extenders
FDA policy issues especially potential 510k review policy changes
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2009 · third_quarter · Q3
International corporate tax reform and Over the Counter financial derivatives issues
FDA issues including 510k process for medical devices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2009 · second_quarter · Q2
National Joint Registry (HR 2813), FDA 510(k) issues, H Res 577 (Orthopedic Resolution) Various health care reform draft bills from the House Tri-Committees and Senate HELP and Finance Committees
Physician Payment Disclosure (Sunshine) bill - cosponsors Sens. Grassley and Kohl Medicare Proposed Inpatient Prospective Payment System Rule for FY10
Patent Reform Bills in the House and Senate
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2009 · first_quarter · Q1
National Joint Registry, 510(k) process with emphasis on Class III 510(k) devices per GAO Report, Reprocessing single use medical devices Physician Payment Sunshine Legislation (co-sponsored by Senators Kohl and Grassley)
Tax deferral, R&D credit, House and Senate Budget Resolutions (H. Con. Res 85 and S. Con Res. 13)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2008 · fourth_quarter · Q4
R&D Tax Credit/CFC Look Thru (tax extenders legislation, H.R. 1424, S.334)
FDA Sentinel Initiative (post market surveillance); H.R. 3580; FDA Guidance Documents; H.R. 3160 - Import Safety; Federal Preemption (S.3398 and H.R. 6381); Direct to Consumer Ads (H.R. 6151)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2008 · third_quarter · Q3
S. 2029 and H.R. 5605 Physician Payment Sunshine Act Medicare CY09 Physician Fee Schedule Proposed Rule S.3408 Comparative Effectiveness Research Act of 2008
Import Safety Legislation (draft discussion bills in House [Rep Dingell] and Senate) Medical Device Safety Act - medical device federal preemption bill Direct-to-Consumer Advertising legislative discussions and Senate Aging Committee hearing FDA Post-Market Surveillance issues/proposals in the area of medical devices
Extension of R&D Tax Credit and CFC Look Thru Provision - separately (H.R. 6049) and as part of the Financial Bailout Bill
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2008 · second_quarter · Q2
Korea price cuts for medical devices China re-registration and price controls
Import Safety Legislation (draft) Federal Preemption for Medical Devices Direct to Consumer Advertising Legislation (proposed)
Tax Extenders Bill (H.R. 6049)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Filing targets: Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Healthcare Reform (The Patient Protection and Affordable Care Act (PPACA) (Pub.L. 111-148)) FDA reform issues
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
International tax reform issues as discussed in context of health care reform proposals - CFC look thru, deferral, check the box, etc.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE